AtaiBeckley Inc. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
3.490
-0.080 (-2.24%)
At close: Mar 20, 2026, 4:00 PM EDT
3.510
+0.020 (0.57%)
After-hours: Mar 20, 2026, 7:45 PM EDT
AtaiBeckley Market Cap
AtaiBeckley has a market cap or net worth of $1.27 billion as of March 20, 2026. Its market cap has increased by 316.17% in one year.
Market Cap
1.27B
Enterprise Value
1.02B
1-Year Change
316.17%
Ranking
Category
Stock Price
$3.49
Market Cap Chart
Since the IPO on June 18, 2021, AtaiBeckley's market cap has decreased from $2.29B to $1.27B, a decrease of -44.61%. That is a compound annual growth rate of -11.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 1.27B | -14.31% |
| Dec 31, 2025 | 1.49B | 565.64% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
| Jun 18, 2021 | 2.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biohaven | 1.34B |
| Palvella Therapeutics | 1.33B |
| Ardelyx | 1.30B |
| Rapport Therapeutics | 1.29B |
| Zenas BioPharma | 1.28B |
| Vir Biotechnology | 1.27B |
| Immatics | 1.26B |
| Taysha Gene Therapies | 1.26B |